Saturday, August 13, 2005

The Island

My wife has beaten me to the punch in posting about it, but we saw the sci fi flick The Island last night. We didn't see it just because Scarlett Johansson was in the film, although that might be a fine reason. We've been seeing a lot of films in the theatres this summer, something we have not done much of for some time. I think we've hit most of the blockbusters and The Island, while not as good as could have been, is not a shabby flick at all. The film is also surprisingly friendly to pro life concerns - Ewan MacGregor and Johansson play a pair of runaway clones, fleeing the facility that created them merely to be an insurance plan for its wealthy clients - one of whom is the president of the United States. The film is beautifully shot, with some terrific lighting that reminded me of Ridley Scott's Black Hawk Down. Scott had nothing to do with this one, however. Micheal Bay directed and he does a pretty fair job. For Bay that means he actually let the story build once and a while, in between long scenes of carnage and mayhem. The carnage and mayhem are well done and there is a highway chase that is almost as good as the one in the second Matrix film. My bones took a beating in that sequence. Still, I wish the story could have been given just a little more depth. It's missing a soliloquy on the sancticy of life. It offers instead Steve Buschemi explaining to MacGregor and Johansson that since they were created by men, they have no souls. The clones look on blankly, and from this I suspect we are to surmise that Buschemi is wrong on both counts. Look, I plant a seed in my back yard, but I can't take the credit for "creating" the plant. All I've done is supply conditions conducive to its growth. The film could milk the wrongness of its premise just a bit better than it does. The gunplay under a broken angel statue is a step in the right direction. The negatives include large, blatant product placement scenes for MSN and Cadillac, a somewhat too low key role for Johansson, and one gaping plot flaw. The plot flaw is that somehow we are to believe that MacGregor's character is the first of a whole batch of clones who has somehow inherited the memories and skills of his original. I'm at a loss as to how that is possible. A clone is built off of the genetic code of the original and that code does not include memories. There is even a name for this discredited theory, Lamarckism. This idea is utterly uncessesary to the film and it actually undermines the premise in some ways, ie. perhaps the cloning would be ok if the memories were not there? Better to just leave it out. If it really was possible to transfer the full identity of an original into a clone, you would have a very different film, one that raises very different questions. It would be less of a film about the sanctity of life and more of a film about the question of identity. If you're intrigued by the questions raised by the idea of 'cut and paste' identities Greg Egan wrote a good novel on the subject called Permutation City. See the Wikkipedia entry here. Egan writes really terrific hard sci fi. The biggest plus remains The Island's premise, which serves to show how a western free market countries can (and do!) engage in Lysenkoism, or the subordination of science to ideology - in this case the ideology of "choice" over all other considerations. Finally, I should mention that the movie is also very violent and not suited to young kids but could be an excellent starting point for discussion with teens. For more on The Island see here. A summer movie re-cap... Worth Seeing - The Island, Batman Begins, The Dukes of Hazzard, and Charlie and the Chocolate Factory. Biggest Disappointment: Revenge of the Sith.

1 comment:

uzby96yqop said...

Big News From The Healthcare Industry!!

+++++++++++Current Profile+++++++++++
Faceprint Global Solutions (FCPG)
Current Price $0.15
A company with hot new identity solution products
and licenses with over 40 current governmental and
non-governmental contracts in negotiations.

Is this an undiscovered gem priced to go higher!!
Please read the following Announcement in its Entirety and Consider the Possibilities�
Watch this One to Trade!

FCPG volume trading is beginning to surge with this landslide Announcement. The value of this
stock appears poised for growth! This one should not remain on the ground floor for long.


Faceprint Global Solutions (FCPG) is pleased to announce that its European partner, Keyvelop, has teamed up with IBM's Partner World Industry Networks to deliver customer software requirement solutions for the international healthcare industry.
With FGS owning the exclusive North American rights to distribute the worlds leading encryption and transmission software developed by Keyvelop, FGS is poised to capture large volumes of sales generated by customers currently using IBM's software in the healthcare and other industries.
With traceability and security now deemed a serious business priority, companies are increasingly focused on employing procedures and controls designed to ensure the authenticity, integrity and confidentiality of electronic records.
"This is a very positive move for FGS and for Keyvelop," said FGS CEO Pierre Cote. "We are very happy about the decision to go with IBM. This is a continuation of the progress made by everyone associated with FGS and its partners."
Buell Duncan, IBM's general manager of ISV & Developer Relations commented, "Collaborating with Keyvelop will ensure that we develop open solutions that are easy to maintain and cost effective for our customers in the healthcare and life sciences industry."
Among other things, this new software technology which is currently being used by a number of European healthcare companies, is used to send any file, regardless of format or size. Encryption keys, evidence of transmission integrity with fingerprint calculation, time-stamping of all actions and status record updating, pre-checking sender and receiver identities, validating file opening dates are part of Keyvelop features.
About FacePrint Global Solutions, Inc.
FGS operates a business, which develops and delivers a variety of technology solutions, including biometric software applications on smart cards and other support mediums (apometric solutions). FGS's products provide biometric solutions for identity authentication and a host of smart card- and biometrics-related hardware peripherals and software applications. Apometrix, FGS's wholly-owned subsidiary, combines on-card or in-chip multi-application management solutions with best-of-breed 'in-card matching' biometrics. Keyvelop's secure digital envelope solution and Apometrix's on-card biometrics work together to produce the winning combination in the fields of security, traceability and identity management. FGS is headquartered in Fresno, California.

The examples above show the Awesome, Earning Potential of little known Companies That Explode onto Investor's Radar Screens. This stock will not be a Secret for long. Then You May Feel the Desire to Act Right Now! And Please Watch This One Trade!

All statements made are our express opinion only and should be treated as such. We may own, take position and sell any securities mentioned at any time. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. This profile is in no way affiliated with the featured company. We were compensated one thousand dollars from third party (IR Marketing) to distribute this report. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects". in compliance with Section 17(b), we disclose the holding of FGS shares prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. Since we own shares, there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward-looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties that could cause results to differ materially from those set forth in the forward- looking statements. This is not solicitation to buy or sell stocks, this text is for informational purpose only and you should seek professional advice from registered financial advisor before you do anything related with buying or selling stocks, penny stocks are very high risk and you can lose your entire investment.